NEW YORK (GenomeWeb) – Quanterix reported after the close of the market on Wednesday that its fourth quarter revenues fell 1 percent year-over-year.

The company posted Q4 revenues of $6.6 million, down from $6.7 million in Q4 2016 and below the consensus Wall Street estimate of $6.7 million.

Quanterix noted that the Q4 2016 figure included $1.8 million of non-recurring license revenue and that Q4 2017 revenues were up 35 percent year-over-year once that non-recurring figure was excluded.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

A new report highlights the potential threats posed by advances in synthetic biology, NPR reports.

A Bloomberg reporter tried to get her genetic data deleted, but found it's not so simple to do.

Johns Hopkins University's Steven Salzberg and his colleagues have come up with a new estimate for the number of human genes, Nature News reports.

In Genome Research this week: study of intra-tumor heterogeneity, workflow resources for EPIGEN-Brazil, and more.